Premium
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 0,00 | Sale to Issuer | - | 35,21M | -0,40% |
| 2026-05-18 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 4,86M | Derivative Exercise and Sale | 33,27 - 37,99 | 3,62M | - |
| 2026-05-04 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 0,00 | Sale to Issuer | - | 35,36M | -0,40% |
| 2026-05-04 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 0,00 | Other Disposition | - | 35,36M | -0,40% |
| 2026-05-04 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 3,57M | Derivative Exercise and Sale | 25,00 - 25,41 | 3,62M | - |
| 2026-04-20 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 0,00 | Sale to Issuer | - | 35,50M | -0,40% |
| 2026-04-20 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 0,00 | Other Disposition | - | 35,50M | -0,40% |
| 2026-04-20 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 4,00M | Derivative Exercise and Sale | 27,74 - 29,51 | 3,62M | - |
| 2026-04-15 | Mr. Peter McGrathSenior VP & CFO | -24,55k | 579,67k | Vente | 23,61 | 113,47k | -17,79% |
| 2026-04-15 | Ms. Anna Chiara JonesSenior VP, General Counsel & Corporate Secretary | -4,91k | 115,94k | Vente | 23,61 | 56,35k | -8,02% |
| 2026-04-15 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -13,75k | 324,63k | Vente | 23,61 | 398,19k | -3,34% |
| 2026-04-15 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -8,45k | 199,42k | Vente | 23,61 | 69,31k | -10,86% |
| 2026-04-06 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 0,00 | Sale to Issuer | - | 35,64M | -0,40% |
| 2026-04-06 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 0,00 | Other Disposition | - | 35,64M | -0,40% |
| 2026-04-06 | Dr. Kamal GhaffarianCo-Founder & Chairman | -141,91k | 3,29M | Derivative Exercise and Sale | 23,03 - 23,65 | 3,62M | - |
| 2026-03-24 | Dr. Kamal GhaffarianCo-Founder & Chairman | -283,82k | 0,00 | Sale to Issuer | - | 35,78M | -0,79% |
| 2026-03-24 | Dr. Kamal GhaffarianCo-Founder & Chairman | -283,82k | 0,00 | Other Disposition | - | 35,78M | -0,79% |
| 2026-03-24 | Dr. Kamal GhaffarianCo-Founder & Chairman | -283,82k | 5,33M | Derivative Exercise and Sale | 17,80 - 20,34 | 3,62M | - |
| 2026-03-19 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -150,00k | 2,63M | Derivative Exercise and Sale | 16,93 - 18,81 | 56,26k | - |
| 2026-03-19 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -150,00k | 0,00 | Sale to Issuer | - | 8,87M | -1,66% |
| 2026-03-19 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -150,00k | 0,00 | Other Disposition | - | 8,87M | -1,66% |
| 2026-02-11 | Mr. Peter McGrathSenior VP & CFO | -25,54k | 445,33k | Vente | 17,44 | 75,52k | -25,27% |
| 2026-02-11 | Ms. Anna Chiara JonesSenior VP, General Counsel & Corporate Secretary | -16,78k | 292,56k | Vente | 17,44 | 48,76k | -25,60% |
| 2026-02-13 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -86,80k | 1,39M | Vente | 16,01 | 376,94k | -18,72% |
| 2026-02-11 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -23,23k | 404,97k | Vente | 17,44 | 56,26k | -29,22% |
| 2026-02-11 | Mr. Steven VonturCAO & Controller | -4,34k | 75,72k | Vente | 17,44 | 36,57k | -10,61% |
| 2026-01-15 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -487,33k | 0,00 | Other Disposition | - | 12,34M | -3,80% |
| 2026-01-15 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -487,33k | 9,78M | Derivative Exercise and Sale | 20,03 - 20,06 | 241,18k | - |
| 2026-01-15 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -487,33k | 0,00 | Sale to Issuer | - | 12,34M | -3,80% |
| 2026-01-15 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -194,34k | 3,90M | Derivative Exercise and Sale | 20,04 - 20,06 | 0,00 | - |
| 2026-01-15 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -194,34k | 0,00 | Other Disposition | - | 9,02M | -2,11% |
| 2026-01-15 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -194,34k | 0,00 | Sale to Issuer | - | 9,02M | -2,11% |
| 2026-01-08 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -12,67k | 253,42k | Derivative Exercise and Sale | 20,00 | 241,18k | - |
| 2026-01-08 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -12,67k | 0,00 | Sale to Issuer | - | 12,83M | -0,10% |
| 2026-01-08 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -5,66k | 113,22k | Derivative Exercise and Sale | 20,00 | 0,00 | - |
| 2026-01-08 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -5,66k | 0,00 | Sale to Issuer | - | 9,21M | -0,06% |
| 2026-01-02 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -500,00k | 9,04M | Derivative Exercise and Sale | 18,04 - 18,08 | 241,18k | - |
| 2026-01-02 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -500,00k | 0,00 | Other Disposition | - | 12,84M | -3,75% |
| 2026-01-02 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -500,00k | 0,00 | Sale to Issuer | - | 12,84M | -3,75% |
| 2025-12-19 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -2,00M | 31,51M | Derivative Exercise and Sale | 15,01 - 16,71 | 241,18k | - |
| 2025-12-19 | Mr. Stephen J. AltemusCo-Founder, President, CEO & Director | -2,00M | 0,00 | Sale to Issuer | - | 13,34M | -13,04% |
| 2025-12-19 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | 242,94k | 0,00 | Derivative Exercise and Retained Stock | - | 0,00 | -100,00% |
| 2025-12-19 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -350,00k | 5,34M | Automatic Disposition | 12,06 - 16,04 | 0,00 | -100,00% |
| 2025-12-19 | Dr. Timothy P. CrainCo- Founder, Senior VP & CTO | -242,94k | 0,00 | Sale to Issuer | - | 9,22M | -2,57% |
| 2025-12-09 | Dr. Kamal GhaffarianCo-Founder & Chairman | -28,14k | 0,00 | Other Disposition | - | 36,07M | -0,08% |
| 2025-12-09 | Dr. Kamal GhaffarianCo-Founder & Chairman | -28,14k | 0,00 | Other Disposition | - | 36,07M | -0,08% |
| 2025-11-15 | Mr. Steven VonturCAO & Controller | -1,34k | 12,76k | Sale to Issuer | 9,53 | 25,02k | -5,08% |
| 2025-11-12 | Mr. Michael BlitzerIndependent Director | 241,08k | 2,19M | Achat | 8,83 - 9,27 | 1,87M | 14,82% |
| 2025-08-24 | Mr. Steven VonturCAO & Controller | -1,83k | 16,38k | Sale to Issuer | 8,97 | 21,36k | -7,88% |
| 2025-07-28 | Dr. Kamal GhaffarianCo-Founder & Chairman | -40,25k | 542,97k | Derivative Exercise and Sale | 13,49 | 3,62M | - |
| 2025-07-28 | Dr. Kamal GhaffarianCo-Founder & Chairman | -40,25k | 0,00 | Sale to Issuer | - | 36,09M | -0,11% |
| 2025-07-17 | Dr. Kamal GhaffarianCo-Founder & Chairman | -40,25k | 483,87k | Derivative Exercise and Sale | 12,02 | 3,62M | - |
| 2025-07-17 | Dr. Kamal GhaffarianCo-Founder & Chairman | -40,25k | 0,00 | Sale to Issuer | - | 36,13M | -0,11% |
| 2025-07-11 | Dr. Kamal GhaffarianCo-Founder & Chairman | -80,51k | 970,07k | Derivative Exercise and Sale | 12,05 | 3,62M | - |
| 2025-07-11 | Dr. Kamal GhaffarianCo-Founder & Chairman | -80,51k | 0,00 | Sale to Issuer | - | 36,17M | -0,22% |
| 2025-06-06 | Dr. Kamal GhaffarianCo-Founder & Chairman | -40,25k | 0,00 | Sale to Issuer | - | 38,74M | -0,10% |
| 2025-06-06 | Dr. Kamal GhaffarianCo-Founder & Chairman | -40,25k | 484,82k | Derivative Exercise and Sale | 12,04 | 3,62M | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
